Deputy Director of the Department of Melanoma and Sarcoma Medical Oncology, Chief Physician, Professor and Doctoral Supervisor. He has been engaged in the clinical diagnosis and treatment of melanoma, sarcoma, renal cell carcinoma and urothelial carcinoma for more than 20 years. His research focuses on the research and development as well as clinical translation of innovative anti‑tumor drugs. He has facilitated the launch of 7 anti‑cancer new drugs and formulated 13 innovative treatment regimens. As the lead writer, he has compiled 3 national‑level guidelines issued by the National Health Commission of the People's Republic of China and revised 2 international guidelines. He has been invited to deliver speeches at European and American oncology conferences on 5 occasions. He is the recipient of the first National Outstanding Young Clinical Scientist Program and has received multiple grants from the National Natural Science Foundation of China. He serves as the Chief Scientist for the Four Major Chronic Diseases Special Project of the National Health Commission and the Principal Investigator for the Excellent Clinical Research Program of Research‑oriented Wards under the Beijing Municipal Health Commission. He was selected for the 4th Batch of Beijing Dengfeng Talent Program. He has published over 100 SCI papers in renowned domestic and international journals including Journal of Clinical Oncology and JAMA Oncology. His research achievements have won numerous awards such as the Second Prize of Beijing Science and Technology Progress Award and the Second Prize of Science and Technology Progress Award from the Chinese Anti‑Cancer Association.